6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Self-Control Deficits in Substance Dependence
Substance dependence significantly impairs self-control, rooted in disruptions in executive functioning and emotional regulation. Prolonged substance use alters brain structures like the prefrontal cortex and anterior cingulate cortex, reducing the ability to resist cravings or delay gratification. These deficits manifest in compulsive drug-seeking behaviors despite adverse consequences. Interventions like cognitive-behavioral therapy (CBT) aim to rebuild self-regulation skills through techniques such as impulse control training and coping strategies for triggers. Mindfulness-based practices also help individuals regain focus and manage emotional distress. By addressing self-control deficits, treatment can empower individuals to break the cycle of addiction and regain autonomy over their actions.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Malasri Chaudhery Malgeri
Recovery com, United States
Jana Furstova
Palacký University Olomouc, Czech RepublicSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States